N
Novavax D
D
NVAX
5.59500
USD
-0.39
(-6.44%)
مغلق
حجم التداول
205,161
الربح لكل سهم
-1
العائد الربحي
-
P/E
-5
حجم السوق
899,923,282
الأخبار المقالات
العنوان: Novavax
القطاع: Healthcare
الصناعة: Biotechnology
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly ownedSwedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. Thecompany manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.